Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected Adults

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this study is to evaluate the safety and immunogenicity of the IHV01 protein vaccine primed and co-administered with HIV DNA CON-S env vaccine in healthy, HIV-1-uninfected adults.
Epistemonikos ID: 8285c388415badff424adcb079ad802f21817156
First added on: May 21, 2024